As with other receptor agonists in this class, the therapeutic effect builds gradually as the dose is escalated and the body adapts to the medicine
Stephen Byrd: It's definitely in years
For women who have tried multiple diet medications or struggled with hormonal weight gain, medical weight loss semaglutide offers a science-backed option
Thyroid tumor risk: Individuals with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should avoid tirzepatide due to the risk of thyroid tumors
GLP-1 RAs may also improve liver function, this effect is thought to involve activation of AMP-activated protein kinase (AMPK), a key metabolic regulator that inhibits fatty acid synthesis and promotes fatty acid -oxidation, leading to decreased lipid accumulation in hepatocytes 22,23,24,25
PMID: 12668216 Pavlova IV et al